OTCMKTS:CCEL

Cryo-Cell International - CCEL Stock Forecast, Price & News

$5.76

+0.15 (+2.67%)

(As of 08/12/2022 12:00 AM ET)

Add

Compare

Today's Range: $5.61
▼
$5.84
50-Day Range: $5.20
▼
$6.58
52-Week Range: $5.00
▼
$14.16

Volume: 4,892 shs
Average Volume: 3,276 shs
Market Capitalization: $48.31 million

P/E Ratio: 30.31
Dividend Yield: N/A
Price Target: N/A

About Cryo-Cell International (OTCMKTS:CCEL) Stock

Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, and auto-immune diseases. The company also manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It stores approximately 500,000 cord blood and cord tissue stem cells worldwide. The company markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. Cryo-Cell International, Inc. was incorporated in 1989 and is headquartered in Oldsmar, Florida.

Receive CCEL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cryo-Cell International and its competitors with MarketBeat's FREE daily newsletter.

CCEL Stock News Headlines

August 2, 2022 | americanbankingnews.com

Cryo-Cell International (OTCMKTS:CCEL) Stock Price Passes Below 200-Day Moving Average of $7.29

July 23, 2022 | americanbankingnews.com

Cryo-Cell International (OTCMKTS:CCEL) Stock Crosses Below 200-Day Moving Average of $7.55

July 15, 2022 | benzinga.com

Cryo-Cell International (NASDAQ:CCEL), Earnings Estimates, EPS, and Revenue

July 15, 2022 | benzinga.com

Cryo-Cell International (NASDAQ:CCEL), Analyst Ratings, Price Targets, Predictions

July 11, 2022 | finance.yahoo.com

Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2022 Financial Results

June 16, 2022 | bizjournals.com

Logistics firm picks Garner for 240K-square-foot warehouse

April 15, 2022 | bizjournals.com

Why this German company is expanding in Knightdale

April 13, 2022 | seekingalpha.com

CRYO-CELL International GAAP EPS of $0.10, revenue of $7.26M

April 13, 2022 | finance.yahoo.com

Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2022 Financial Results

March 23, 2022 | bizjournals.com

Stem cell firm launching Durham facility to attract business

March 18, 2022 | morningstar.com

Cord Blood Banking Leader Cryo-Cell Announces Extravault Biorepository Service | Morningstar

March 16, 2022 | finance.yahoo.com

Cord Blood Banking Leader Cryo-Cell Announces Extravault Biorepository Service

March 9, 2022 | finance.yahoo.com

Cryo-Cell Shares Its 2021 Annual Letter to Shareholders

February 22, 2022 | seekingalpha.com

CRYO-CELL International GAAP EPS of $0.00, revenue of $28.9M

February 22, 2022 | finance.yahoo.com

Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2021

January 15, 2022 | nasdaq.com

Cryo-Cell International, Inc. Common Stock (CCEL)

December 20, 2021 | benzinga.com

How 2020's Hottest IPOs Have Performed In 2021

October 27, 2021 | finance.yahoo.com

Cord Blood Banking Leader Cryo-Cell Announces Its Intent to Advance Clinical Trials

October 15, 2021 | benzinga.com

Cryo-Cell Reports Q3 2021 Revs $7.5M

October 15, 2021 | finance.yahoo.com

Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2021 Financial Results

September 21, 2021 | nasdaq.com

Cryo-Cell International, Inc. Shares Near 52-Week Low - Market Mover

September 20, 2021 | finance.yahoo.com

Cryo-Cell International Announces Changes To Its Board of Directors

September 11, 2021 | bizjournals.com

Stem cell firm that partners with Duke University grabs space in Durham

August 30, 2021 | finance.yahoo.com

Cryo-Cell International Announces Uplisting to The Nasdaq Capital Market

August 20, 2021 | finance.yahoo.com

Cryo-Cell International Completes Acquisition of Real Estate Property for Its Institute for Cellular Therapies

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive CCEL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cryo-Cell International and its competitors with MarketBeat's FREE daily newsletter.

CCEL Company Calendar

Last Earnings: 7/11/2022
Today: 8/14/2022
Next Earnings (Estimated): 10/13/2022
Fiscal Year End: 11/30/2022

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Industry: Miscellaneous health & allied services, not elsewhere classified
Sub-Industry: N/A
Sector: Medical
Current Symbol: OTCMKTS:CCEL
CUSIP: N/A
CIK: 862692
Web: www.cryo-cell.com
Phone: (813) 749-2100
Fax: 813-855-4745
Employees: 83
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): $0.19
Trailing P/E Ratio: 30.31
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $2.08 million
Net Margins: 5.68%
Pretax Margin: 6.98%
Return on Equity: 38.25%
Return on Assets: 2.93%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 0.66
Quick Ratio: 0.60

Sales & Book Value

Annual Sales: $28.89 million
Price / Sales: 1.67
Cash Flow: $0.42 per share
Price / Cash Flow: 13.80
Book Value: $0.49 per share
Price / Book: 11.75

Miscellaneous

Outstanding Shares: 8,390,000
Free Float: 5,146,000
Market Cap: $48.31 million
Optionable: Not Optionable
Beta: 0.54

Key Executives

Mr. David I. Portnoy (Age 59)
Chairman & Co-CEO
Comp: $1.22M
Mr. Mark L. Portnoy (Age 58)
Co-CEO & Director
Comp: $873.34k
Ms. Jill M. Taymans (Age 52)
CFO & VP of Fin.
Comp: $205.42k
Mr. Oleg Mikulinsky (Age 49)
Chief Information Officer
Comp: $326.35k
Dr. Joanne Kurtzberg M.D.
Medical Director and Member of Medical & Scientific Advisory Board

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

CCEL Stock - Frequently Asked Questions

How have CCEL shares performed in 2022?: Cryo-Cell International's stock was trading at $11.60 at the beginning of the year. Since then, CCEL stock has decreased by 50.4% and is now trading at $5.7581.
View the best growth stocks for 2022 here.
When is Cryo-Cell International's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, October 13th 2022.
View our CCEL earnings forecast.
How were Cryo-Cell International's earnings last quarter?: Cryo-Cell International, Inc. (OTCMKTS:CCEL) issued its quarterly earnings data on Monday, July, 11th. The company reported $0.07 earnings per share for the quarter. The business had revenue of $7.63 million for the quarter. Cryo-Cell International had a trailing twelve-month return on equity of 38.25% and a net margin of 5.68%.
What other stocks do shareholders of Cryo-Cell International own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Cryo-Cell International investors own include NVIDIA (NVDA), Overstock.com (OSTK), Avid Technology (AVID), Boeing (BA), Enphase Energy (ENPH), OPKO Health (OPK), Riot Blockchain (RIOT), Aldeyra Therapeutics (ALDX), Alimera Sciences (ALIM) and Allena Pharmaceuticals (ALNA).

What is Cryo-Cell International's stock symbol?: Cryo-Cell International trades on the OTCMKTS under the ticker symbol "CCEL."
Who are Cryo-Cell International's major shareholders?: Cryo-Cell International's stock is owned by a variety of retail and institutional investors. Top institutional investors include Massmutual Trust Co. FSB ADV (1.47%). Insiders that own company stock include Brian L Sheehy, David Portnoy, George Gaines and Mark L Portnoy.
View institutional ownership trends.
How do I buy shares of Cryo-Cell International?: Shares of CCEL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Cryo-Cell International's stock price today?: One share of CCEL stock can currently be purchased for approximately $5.76.
How much money does Cryo-Cell International make?: Cryo-Cell International (OTCMKTS:CCEL) has a market capitalization of $48.31 million and generates $28.89 million in revenue each year. The company earns $2.08 million in net income (profit) each year or $0.19 on an earnings per share basis.
How can I contact Cryo-Cell International?: Cryo-Cell International's mailing address is 700 Brooker Creek Boulevard Suite 1800, Oldsmar FL, 34677. The official website for the company is www.cryo-cell.com. The company can be reached via phone at (813) 749-2100, via email at investors@cryo-cell.com, or via fax at 813-855-4745.

This page (OTCMKTS:CCEL) was last updated on 8/14/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

MarketBeat Resources